Funded Startups in Las Condes
In the Las Condes list (15 rows), the largest disclosed round is Xepelin’s $140M Debt Financing on 2022-09-09, which dwarfs the next-highest disclosed amou…
In the Las Condes list (15 rows), the largest disclosed round is Xepelin’s $140M Debt Financing on 2022-09-09, which dwarfs the next-highest disclosed amounts in the view ($30M Elevva on 2022-05-13 and $30K Queritel.com on 2024-02-08; the other disclosed entries cluster below $20M). That same pattern shows up in stage sizing: there are four disclosed $2M rounds (VMetrix on 2025-05-13 is $3M, while several others are $2M) but the financial-services line is where disclosed scale spikes, especially around Xepelin and Cordada ($15M Debt Financing on 2022-08-02).
The time window is also concentrated. Rounds span 2021-10-18 (AVLA) through 2025-06-03 (Orionx), with six of the 15 entries dated 2022 (from 2022-05-13 through 2022-11-14). On classification, “Series Unknown” appears for two companies (Queritel.com in 2024-02-08 at $30K; AVLA in 2021-10-18 at $7M), and “undisclosed” appears for three entries (Orionx on 2025-06-03; Xpendit on 2025-01-01; both without amounts).
Most recent rounds
15 shownRelated listings
Frequently asked
What’s the largest disclosed round in Las Condes here, and how does it compare to the rest of the disclosed amounts?
Xepelin’s $140M Debt Financing on 2022-09-09 is the only disclosed round in the table anywhere near that scale; the next-largest disclosed amounts visible are $30M (Elevva on 2022-05-13) and $17M (Examedi on 2022-06-22). Most other disclosed rounds sit at $15M or below (e.g., Cordada $15M on 2022-08-02; HealthAtom $10M on 2023-01-06).
Are there date clusters in these 15 most recent Las Condes rounds?
Yes. Six entries fall in 2022 (Queritel.com is 2024, so these are all 2022 dates: 2022-05-13 Elevva $30M; 2022-06-22 Examedi $17M; 2022-08-02 Cordada $15M; 2022-09-09 Xepelin $140M; 2022-11-14 ObraLink $2M; plus the 2022-09-09/11-14 spread). Recent months also show activity: three entries occur after 2025-01-01 (Xepelin is 2025-01-01 undisclosed, VMetrix is 2025-05-13 for $3M, and Orionx is 2025-06-03 undisclosed).
Which sectors look over-represented across these rows?
Financial Services appears repeatedly: VMetrix (2025-05-13), Xpendit (2025-01-01), Btrust (2024-05-17), Xepelin (2022-09-09), Cordada (2022-08-02), and AVLA (2021-10-18). Healthcare is also recurring with HealthAtom (2023-01-06) and Examedi (2022-06-22), while other sectors appear once or twice (e.g., Apps: Retorna 2024-06-26 and Floid 2021-12-01).
How concentrated are the stage labels, and do “Series Unknown” or “undisclosed” amounts affect the interpretation?
Seed is common (e.g., VMetrix 2025-05-13 for $3M; Retorna 2024-06-26 for $1M; Btrust 2024-05-17 for $2M; Regcheq 2023-07-07 for $2M; ObraLink 2022-11-14 for $2M; Floid 2021-12-01 for $2M). “Series Unknown” appears for two companies (Queritel.com on 2024-02-08 at $30K and AVLA on 2021-10-18 at $7M), while three entries are “undisclosed” (Orionx 2025-06-03; Xpendit 2025-01-01; also Orionx is the only 2025 undisclosed beyond Xpendit), limiting any disclosed-size comparison for those rounds.
Which entries are the clearest outliers for diligence beyond just the amounts?
The most obvious funding-size outlier is Xepelin’s $140M Debt Financing (2022-09-09) versus the rest of the disclosed rounds. On the low end, Queritel.com’s $30K (2024-02-08) is the smallest disclosed amount in the table, sitting far below other sub-$1M entries like Retorna’s $1M (2024-06-26) and the $2M cluster (e.g., Regcheq 2023-07-07 and ObraLink 2022-11-14).
What’s the most recent and oldest dated round in this view, and how much of the timeline they cover?
The most recent dated entry is Orionx on 2025-06-03 (undisclosed). The oldest is AVLA on 2021-10-18 (Venture - Series Unknown, $7M), so the visible timeline spans roughly three years and change across these 15 rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.